Reviparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH).
Medical uses Prevention of blood clots Prophylaxis of perioperative thromboembolism Treatment of DVT with or without pulmonary embolism (PE) Prophylaxis of acute thrombotic events after percutaneous transluminal coronary angioplasty (PTCA)
Chemistry Reviparin is a low molecular weight heparin obtained by nitrous acid depolymerization of heparin extracted from porcine intestinal mucosa. Its structure is characterized, for the most part, by a group of 2-O-sulfo-α-lidopyranosuronic acid. The average molecular weight is about 3900 daltons.
References
External links reviparin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Yusuf S, Mehta SR, Xie C, et al. (2005). "Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation". JAMA. 293 (4): 427–35. doi:10.1001/jama.293.4.427. PMID 15671427.


